AP NEWS
Press release content from BusinessWire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from BusinessWire
Press release content from BusinessWire. The AP news staff was not involved in its creation.

Worldwide Molecular Diagnostics Market Size, Growth & Share: 2019-2024 - ResearchAndMarkets.com

January 24, 2019

DUBLIN--(BUSINESS WIRE)--Jan 24, 2019--The “Molecular Diagnostics Market Size, Growth, Share- Segmented by Technology, by Application, and by Product, End User, and Geography - Trends and Forecast (2019 - 2024).” report has been added to ResearchAndMarkets.com’s offering.

The global molecular diagnostics market has been estimated at around USD 7000 million in 2017. The market is expected to register a CAGR of approximately 9% during the forecast period 2018 to 2023.

North America accounted for the largest market, followed by Europe, in the molecular diagnostics market. Asia-Pacific was estimated to register approximately 15% CAGR through the forecast period, 2018-2023.

Point-of-care testing is an emerging field in diagnostics. The PoC tests are widely accepted because many tests are portable, fast, fairly simple to use, and inexpensive. Along with other factors, such as large outbreaks of bacterial and viral epidemics in the world, the rapidly evolving technology is driving the molecular diagnostics market.

Market Dynamics

Drivers

Large Outbreaks of Bacterial and Viral Epidemics in the World Increasing Demand for Point-of-Care Diagnostics Pharmacogenomics Rapidly Evolving Technology

Restraints

Economic Turndown Need for High-Complexity Testing Centers Limited Budget

Topics Covered

1. Introduction

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Molecular Diagnostics Market Overview

6. Drivers, Restraints, Opportunities and Challenges Analysis (DROC)

7. Market Segmentation

8. Molecular Diagnostics Market Competitive Landscape

9. Molecular Diagnostics Market Key Players

10. Future of the Molecular Diagnostics Market

Companies Featured

Roche Diagnostics Illumina Inc. Hologic Corporation Agilent Technologies/Dako Qiagen Myriad Genetics Abbott Laboratories Cepheid Inc. Genomic Health Inc. Grifols SA

For more information about this report visit https://www.researchandmarkets.com/research/x32n5j/worldwide?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20190124005405/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Molecular Diagnostics

KEYWORD:

INDUSTRY KEYWORD: OTHER SCIENCE SCIENCE

SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 01/24/2019 08:08 AM/DISC: 01/24/2019 08:08 AM

http://www.businesswire.com/news/home/20190124005405/en